Evidence for Action: A critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users

References 

1. Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295–2303
   • MEDLINE
   • CrossRef
2. Ball A. Policies and interventions to stem HIV-1 epidemics associated with injecting drug use. In:  Stimson GV,  Des Jarlais DC,  Ball A editor. Drug injecting and HIV infection. London: UCL Press; 1998;
3. Rhodes T, Simic M. Transition and the risk environment. British Medical Journal. 2005;331:220–223
4. The Global Fund to Fight AIDS, Tuberculosis and Malaria. (2005). Investing in the future: The global fund at three years. Geneva: The Global Fund.
5. UNODC. (1998, June). Political declaration, guiding principles of drug demand reduction (pp. 8–10). Special session of the general assembly devoted to countering the world drug problem together. Vienna.
6. UNAIDS. (2000). Preventing the transmission of HIV among drug abusers. A position paper of the United Nations System. Geneva: UNAIDS.
7. UNAIDS. (2001). United Nations declaration of commitment on HIV/AIDS of the United Nations General Assembly Special Session on HIV/AIDS “Global Crisis and Global Action” (Resolution 55/16, 25–27 June 2001).
8. UNAIDS. (2005). Joint UNAIDS statement on HIV prevention and care strategies for drug users. Geneva: UNAIDS (http://www.unaids.org).
9. WHO. (2003). Global Health Sector Strategy for HIV/AIDS 2003–2007. Geneva: Department of HIV/AIDS (http://www.who.int/hiv/pub/advocacy/en/GHSS_E.pdf).
10. WHO. (2004a). Advocacy guide: HIV/AIDS prevention among injecting drug users. Geneva: WHO.
11. WHO. (2004b). Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users: Evidence for Action Technical Papers (http://www.who.int/hiv/pub/prev_care/en/effectivenesssterileneedle.pdf).
12. WHO. (2004c). Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users: Evidence for Action Technical Papers (http://www.who.int/hiv/pub/prev_care/en/evidenceforactionreprint2004.pdf).
13. WHO. (2004d). Policy brief: Provision of sterile injecting equipment to reduce HIV transmission. WHO/HIV/2004.03 (http://www.who.int/hiv/pub/advocacy/en/provisionofsterileen.pdf).
14. WHO. (2004e). Policy brief: Reduction of HIV transmission through drug-dependence treatment. WHO/HIV/2004.04 (http://www.who.int/hiv/pub/advocacy/en/drugdependencetreatmenten.pdf).
15. WHO. (2004f). Policy brief: Reduction of HIV transmission in prisons. WHO/HIV/2004.05 (http://www.who.int/hiv/pub/advocacy/en/transmissionprisonen.pdf).
16. WHO. (2004g). Policy brief: Reduction of HIV transmission through outreach. WHO/HIV/2004.02 (http://www.who.int/hiv/pub/advocacy/en/throughoutreachen.pdf).
17. WHO. (2005). Effectiveness of drug dependence treatment in preventing HIV among injecting drug users: Evidence for Action Technical Papers (http://www.who.int/hiv/pub/idu/en/drugdependencefinaldraft.pdf).